UPC MAP

How do the EPC and UPC interact

To ensure that patentees obtain patent coverage that meets the business’ needs both geographically and economically, it is important to understand how the European Patent (39 EPC countries plus 1 extension and 5 validation states) and the Unitary Patent (only available to EU Member States) will interact.

Currently, Unitary Patents (UPs) do not cover all 24 participating EU Member States as only 18 EU Member States have ratified the UPC Agreement to date. Outstanding ratifications are likely to take place successively, so there may be different generations of UPs with different territorial coverage. The coverage of a given generation of UP will stay the same for the entire lifetime, irrespective of any subsequent ratifications of the UPC Agreement after the date of registration of unitary effect.

Select from the list of countries below to understand what patenting and enforcement options are available now the UPC is live.

EPC (EU) country has joined UPC
EPC (EU) country intends to join UPC
EPC (EU) country signed but not ratified UPC
EPC (EU) country - not joining UPC
EPC (Non-EU) country - cannot join UPC
Local & Regional Divisions (infringement)
Central Divisions (revocation/DNI)
Court of Appeal / UPC Registry
Mediation & Arbitration Centres

*Germany ratified the UPC Agreement on 17 February 2023 – this means that the Unified Patent Court and Unitary Patent will go live on 1 June 2023

**The Irish government has committed to a referendum on ratifying the UPC Agreement before May 2024.

Latest updates

PRESS RELEASE – HGF strengthens European presence with three new Partners in France and Germany

HGF is pleased to announce the arrival of three new partners, further strengthening its European presence. Two partners will be joining the firm’s fast-growing French practice, and one will join …

Read article

G1/23: The Enlarged Board of Appeal shift EPO practice towards an “on-sale” bar.

Last week, the EPO’s Enlarged Board of Appeal (EBA) issued its Decision that both a product put on the market before the date of filing of a European patent application, …

Read article

The EPO Board of Appeal comments on the scope of the morality exclusion from patentability

The recent decision, T1553/22 of the Board of Appeal required the Board to consider the scope of the exclusions from patentability under Article 53(a) EPC. The invention in this case …

Read article

Welcome to HGF Presents - New Video Series

Introducing HGF Presents a new video series delivering practical insights into European Patent Law and practice. Curated by our leading experts in chemistry, life sciences, technology & engineering, each concise …

Read article

Seminar on Incorporating Trade Secrets into your IP Strategy

HGF is hosting a Seminar on Incorporating Trade Secrets into your IP Strategy which will be followed by networking, apero, and snacks. The Seminar will be held on Wednesday, 10th …

Read article

Providing Enabling Disclosure for AI inventions at the EPO

  Video overview: The equivalent to the enablement requirement in the US at the EPO is Sufficiency. There is an increasing trend for the sufficiency of AI related patent applications …

Read article

Personalised Medicine Patenting of Known Drugs for Known Indications at the EPO

Video overview: The identification of specific sub-groups of patients to treat with a known drug, even if said patients may have been treated before with the drug, can yield patentable …

Read article